Advanced Bio-Hybrid Materials for Drug Delivery Systems - New Trends and Perspectives

Dear Colleagues,

Due to pollution of our environment, unhealthy lifestyle, as well as stress, causing a variety of chronic disorders, currently, both, the medical and pharmaceutical markets are developing at an intense rate. People need new solutions. Therefore, it is important to consider what the new trends are, as well as possible novel perspectives. There are so many questions related to this topic. This is why recently, many groups of scientists are focusing on the preparation and advanced functional bio-hybrid materials for biomedical applications and drug delivery systems. We can distinguish different systems based on polymeric, organic, inorganic micro/nanocarriers or their combination with biopolymeric, polymeric or hydrogel matrices, which enables the controlled, sustained or modified release of active substances derived from natural or synthetic origin. In addition to the synthesis, physicochemical and structural properties, it is very important to determine the drug release profile and ensure a safe therapeutic concentration. Moreover, from an application point of view, the cytotoxicity assays are essential. I believe that together we can make more, leading to a significant change in people’s quality of life.

This Special Issue will allow us to share achieved goals and new approaches in designing smart drug delivery systems.

Dr. Katarzyna Bialik-Wąs
Dr. Katarzyna Malarz
Dr. Małgorzata A. Miastkowska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.